References
- Pizzo P. A. Management of fever in patients with cancer and treatment-induced neutropenia. New England Journal of Medicine 1993; 328: 1323–1332
- Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 1999; 340: 448–454
- Rose P. E., Johnsdon S. A., Meakin M., Mackie P. H., Stuart J. Serial study of C-reactive protein in leukaemia. Journal of Clinical Pathology, 34: 263–266
- Starke I. D., de Beer F. C., Donnelly J. P., Catovsky D., Goldman J. M., Galton D. A., Pepys M. B. Serum C-reactive protein levels in the management of infection in acute leukaemia. European Journal of Cancer & Clinical Oncology 1984; 20: 319–325
- Gozzard D. I., French E. A., Blecher T. E., Powell R. J. C-reactive protein levels in neutropenic patients with pyrexia. Clinical & Laboratory Haematology 1985; 7: 307–316
- Henly D., Lewis I. J., Evans S. W., Banks R., Bailey C. C., Whicher J. T. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. Journal of Infectious Disease 1992; 165: 886–890
- Riikonen P., Saarinen U. M., Teppo A. M., Metsarinne K., Fyhrquist F., Jalanko H. Cytokine and acute-phase reactant levels in serum of children with cancer admitted for fever and neutropenia. Journal of Infectious Disease, 166: 432–436
- Katz J. A., Mustafa M. M., Bash R. O., Cash J. V., Buchanan G. R. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatric Infectious Disease Journal 1992; 11: 708–712
- Rintala E., Irjala K., Nikoskelainen J. Value of measurement of C-reactive protein in febrile patients with hematological malignancies. European Journal of Clinical Microbiology & Infectious Disease 1992; 11: 973–978
- Santolaya M. E., Cofre J., Beresi V. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia. Clinical Infectious Disease 1994; 18: 589–595
- Herrmann J. L., Blanchard H., Brunengo P., Lagrange P. H. TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values. Infection 1994; 22: 309–315
- Engervall P., Granstrom M., Andersson B., Bjorkholm M. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever. European Journal of Haematology 1995; 54: 226–234
- Manian F. A. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clinical Infectious Disease 1995; 21: 114–121
- Abrahamsson J., Pahlman M., Mellander L. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy. Acta Paediatrica 1997; 86: 1059–1064
- Engel A., Mack E., Kern P., Kern W. V. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 1998; 26: 213–221
- Lehrnbecher T., Venzon D., de Hass M., Chanock S. J., Kul J. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clinical Infectious Disease 1999; 29: 414–419
- de Bont E. S., Vellenga E., Swaanenburg J. C., Fidler V., Visser-van Brummen P. J., van Brummen P. J., Kamps W. A. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. British Journal of Haematology 1999; 107: 305–380
- Zweig M. H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry 1993; 39: 561–577